Feasibility of ex vivo FDG PET of the colon.

Radiology 2009 Jul;252(1):232-9

Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10023, USA.

To facilitate future direct correlations between fluorine 18 fluorodeoxyglucose (FDG)-avid colonic lesions and immunohistochemical assay findings, the authors tested the feasibility of ex vivo FDG positron emission tomography (PET) of the colon resected from humans. In this institutional review board-approved, HIPAA-compliant study, the authors, after obtaining informed patient consent, injected FDG intraoperatively in five patients with neoplasms and imaged their resected colons approximately 3 hours later. The colon could be imaged during this fairly limited time interval, and polyps and cancers could be identified. No biologic tissue degradation occurred. The authors concluded that ex vivo FDG PET of the colon is feasible and, when combined with careful histologic and immunohistochemical analyses, may serve as a research tool to determine the mechanisms of the normal colonic uptake of FDG and the localization of FDG in polyps and cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2522081864DOI Listing
July 2009
12 Reads

Publication Analysis

Top Keywords

vivo fdg
12
pet colon
12
polyps cancers
8
fdg pet
8
feasibility vivo
8
fdg
6
hours colon
4
colons hours
4
resected colons
4
colon imaged
4
imaged resected
4
time interval
4
interval polyps
4
neoplasms imaged
4
limited time
4
fairly limited
4
imaged fairly
4
fdg intraoperatively
4
authors obtaining
4
study authors
4

Similar Publications